Eli Lilly is the clear frontrunner to be the largest pharmaceutical stock in 2034. See what its prospects are for the next ...

Pharmaceutical stocks largely shook off the brunt of negotiated drug prices. But that doesn't mean they'll be spared election noise.

The good news is that if you're willing to put in a bit of effort, it's very possible to improve on your process to secure ...

The Company has granted to the underwriters a 45-day option to purchase up to an additional 232,500 shares of common stock at the public offering price of $4.00 per share, less underwriting discounts ...

Vaishali Parekh has recommended three stocks to buy today —Deepak Fertilisers, RCF, and Aditya Birla Fashion & Retail.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

The drop in interest rate is slightly bigger than anticipated and good news for the biotech industry, but little will change ...

The stock market appears to be at a turning point. While major indexes are still hovering near record levels, there ...

The Indian biotechnology sector is a rapidly advancing segment within the economy, often referred to as a sunrise sector due ...

By Bharath Rajeswaran BENGALURU (Reuters) -Indian shares recovered from a lacklustre start to end higher on Tuesday, with IT ...

Analyst Paul Choi of Goldman Sachs maintained a Buy rating on Ascendis Pharma (ASND – Research Report), boosting the price target to ...

Before the trading day starts we bring you a digest of the key news and events that are likely to move markets. Today we look ...